Envoy Medical, Inc.
COCH
$0.84
$0.045.07%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -25.18% | -26.49% | -28.62% | -28.80% | 15.35% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -25.18% | -26.49% | -28.62% | -28.80% | 15.35% |
| Cost of Revenue | 0.12% | -2.07% | 10.43% | -2.37% | 20.97% |
| Gross Profit | -13.12% | -12.14% | -36.73% | -16.44% | -24.08% |
| SG&A Expenses | -7.25% | -8.86% | -13.81% | -4.41% | 50.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.03% | -1.25% | -0.52% | 4.19% | 46.85% |
| Operating Income | 4.77% | 0.86% | 0.09% | -4.76% | -47.37% |
| Income Before Tax | -3.40% | -56.96% | 14.55% | 30.29% | 42.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.40% | -56.96% | 14.55% | 30.29% | 42.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.40% | -56.96% | 14.55% | 30.29% | 42.13% |
| EBIT | 4.77% | 0.86% | 0.09% | -4.76% | -47.37% |
| EBITDA | 5.26% | 1.33% | 0.40% | -4.57% | -47.31% |
| EPS Basic | -1.25% | -65.25% | 24.85% | 44.63% | 60.65% |
| Normalized Basic EPS | 4.53% | 3.02% | 53.03% | 49.47% | 53.87% |
| EPS Diluted | -1.46% | -63.95% | 24.97% | 44.65% | 60.67% |
| Normalized Diluted EPS | 4.53% | 0.48% | 52.41% | 48.81% | 53.32% |
| Average Basic Shares Outstanding | 8.55% | 17.44% | 29.88% | 46.73% | 83.67% |
| Average Diluted Shares Outstanding | 8.55% | 15.69% | 27.67% | 43.80% | 79.25% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.28% | -- | -- | -- | -- |